Pfizer weighing sale of women's health portfolio - Bloomberg

Pfizer weighing sale of women's health portfolio - Bloomberg
FILE PHOTO: A man walks past Pfizer's world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo -
Andrew Kelly(Reuters)
Text size Aa Aa

(Reuters) - U.S. drugmaker Pfizer Inc <PPE.N> is considering options, including a sale of its women's health portfolio, Bloomberg reported on Thursday, citing sources familiar with the matter.

A sale of the division, which has annual sales of about $1.2 billion, could fetch about $2 billion and draw bids from both private equity firms and rival pharmaceutical companies, Bloomberg reported

Pfizer did not immediately respond to Reuters request for comment.

Allergan Plc <AGN.N> said in May it planned to sell off its women's health and infectious disease units, to focus on its core businesses.

(Reporting by Manogna Maddipatla in Bengaluru; Editing by Shailesh Kuber)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.